South Korean healthcare AI and robotics firm Airs Medical has completed its series C funding round, securing $20m from seven institutional investors in Korea.

The investment, led by BSK Investment and Shinyoung Securities, underscores confidence in the company’s flagship product, SwiftMR, and in its mission to improve preventive healthcare through technology.

SwiftMR (airsmed.com/en/swiftmr) uses deep learning technology to enhance magnetic resonance imaging (MRI) scan speeds by as much as 50% compared with the standard of care. On average, radiology centres and hospitals that integrate SwiftMR achieve a 38% increase in patient throughput and a 22% reduction in business hours, leading to $44,000 per month in additional revenue and an $8000 reduction in monthly operating costs.

SwiftMR is a scan time reduction product with whole pulse-sequence coverage and true super resolution. This technology has set a standard in diagnostic imaging, helping address critical roadblocks radiology centres and hospitals face, such as long patient wait times and the downstream effects of delayed diagnoses.

A frequent problem in healthcare is the delayed diagnosis of patients, often after symptoms have advanced. This, along with resource shortages, results in worse outcomes.

Airs Medical is paving the way to detect diseases proactively before they manifest. Through AI and robotics, it is using diagnostics and prognostics, reducing costs and increasing the accessibility of MRI scans. Ultimately, this helps patients with conditions such as dementia, stroke and cancer receive early diagnoses and improve their chances of better health.

Airs Medical is rapidly expanding. SwiftMR was initially launched in Korea in 2021. By 2023, the technology had successfully entered the USA and Europe, markets that now account for over half of the company’s annual recurring revenue.

“We’re thrilled to receive this substantial support from our investors,” said Hyeseong Lee, CEO of Aits Medical. “This funding will empower us to increase access to preventive healthcare services and create a healthier future for people around the globe.”

With this latest round of funding, Airs Medical (airsmed.com) is poised to accelerate its growth and innovate beyond the SwiftMR. The company plans to expand its presence in international markets, invest in research and development, and ultimately improve patient outcomes worldwide.